Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R21CA240479
National Cancer Institute NCI
Grant: R01CA189986
National Cancer Institute NCI
Grant: R01CA217788
NIH NIAID
Grant: T32 AI 007140
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: T32AI083203
NCI NIH HHS
Grant: R01 CA097934
National Institutes of Health
Grant: 5R01CA189986-03
KSHV alteration of cellular metabolism
National Institutes of Health
Grant: 5T32AI007140-18
STD/AIDS RESEARCH TRAINING GRANT
National Institutes of Health
Grant: 5R01CA217788-02
KSHV immortalization of human lymphatic endothelial cells
National Institutes of Health
Grant: 1T32AI083203-01
Viral Pathogenesis Training Program
National Institutes of Health
Grant: 5R21CA240479-02
Cellular Requirements for KSHV Latency in Endothelial Cells
FWCI
1.19
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals